PIRS שווי כולל של נכסי החברה Pieris Pharmaceuticals Inc

The price visualization on GURU.Markets, which assists in the basic asset valuation, shows that Pieris Pharmaceuticals (PIRS) has total assets amounting to 163.66. Pieris Pharmaceuticals (PIRS) develops original protein structures that replace standard antibodies to protect patents. This foundation enables the creation of precision treatments for oncology and lung pathologies. The business is currently undergoing a complex reorganization and a search for a buyer, strictly limiting its existing cash reserves.

Assessing resource quality requires an analysis of total assets and liabilities, which in this metric are reverse-calculated via return on assets (ROA) to determine the actual capital base. By analyzing the current level of total assets, an investor can identify the fundamental basis of the company, which at Pieris Pharmaceuticals (PIRS) is supported by the capitalization of the proprietary Anticalin platform and stable licensing revenues.